Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Hospitalization* ; Lung Neoplasms*/epidemiology; Male ; Humans ; Female ; Hospital Mortality ; Spain/epidemiology ; Retrospective Studies

Background: Lung cancer is the third most frequent tumor and the main cause of death by tumor in Spain. Although the incidence and mortality are still significantly higher in men than in women, the disparity between the sexes is decreasing. The objective of this study was to analyze the evolution of lung cancer hospitalization and in-hospital mortality rates in Spain from 2010 to 2020.
Methods: The reports of the Minimum Basic Data Set (MBDS) at hospital discharge were used to retrospectively analyze the data of all patients with a primary diagnosis of lung cancer, according to the International Classification of Diseases (ICD-9-CM and ICD-10-CM).
Results: Between 2010 and 2020, there were 315,263 hospitalizations and 70,490 deaths from lung cancer in Spain, the majority (~ 80%) in men. Overall, the rates of hospitalization and in-hospital mortality from lung cancer showed a downward trend throughout the period, although the number of new diagnoses and the absolute number of deaths in women increased. Due to the aging of the population, the degree of comorbidity in patients with lung cancer, although it remains relatively low, is also on the rise.
Conclusion: Lung cancer represents a substantial clinical and economic burden for patients and for the National Health System, so it is necessary to promote primary prevention campaigns, as well as to develop more effective population screening measures to detect cancers early and increase the patient survival.
(© 2022. The Author(s).)

Arch Bronconeumol (Engl Ed). 2021 Feb;57(2):115-121. (PMID: 32600851)
J Geriatr Oncol. 2016 Jul;7(4):249-57. (PMID: 26725537)
Eur J Cancer Prev. 2018 Jul;27(4):296-302. (PMID: 28379885)
Lung Cancer. 2009 Nov;66(2):262-7. (PMID: 19299032)
J Intern Med. 2022 Jul;292(1):68-80. (PMID: 35253286)
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1025-36. (PMID: 24836468)
Arch Bronconeumol. 2016 Aug;52(8):411-9. (PMID: 26970841)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Adicciones. 2007;19(3):273-87. (PMID: 17724929)
Ann Oncol. 2002 Jul;13(7):1087-93. (PMID: 12176788)
Cancer Epidemiol. 2017 Aug;49:66-74. (PMID: 28586708)
Biochim Biophys Acta. 2015 Dec;1856(2):189-210. (PMID: 26297204)
N Engl J Med. 2011 Aug 4;365(5):395-409. (PMID: 21714641)
Lung Cancer Manag. 2020 Jun 22;9(3):LMT34. (PMID: 32774466)
Nat Rev Clin Oncol. 2019 Jun;16(6):341-355. (PMID: 30718843)
Rev Esp Salud Publica. 2019 Jul 15;93:. (PMID: 31285417)
Sci Rep. 2018 Jul 13;8(1):10640. (PMID: 30006595)
Eur Respir Rev. 2022 Jan 12;31(163):. (PMID: 35022255)
Oncotarget. 2017 Dec 28;9(7):7272-7273. (PMID: 29484108)
Clin Transl Oncol. 2014 Jun;16(6):517-28. (PMID: 24277573)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
CA Cancer J Clin. 2020 Jan;70(1):7-30. (PMID: 31912902)
J Thorac Dis. 2019 Jun;11(6):2251-2266. (PMID: 31372262)
BMJ. 2010 Jan 21;340:b5569. (PMID: 20093278)
Pathol Oncol Res. 2021 Apr 30;27:598862. (PMID: 34257553)
Curr Opin Oncol. 2022 Jan 1;34(1):36-43. (PMID: 34652284)
Eur J Intern Med. 2016 Oct;34:94-97. (PMID: 27499180)
ERJ Open Res. 2021 Dec 27;7(4):. (PMID: 34988220)
J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
Tob Control. 2012 Mar;21(2):96-101. (PMID: 22345230)
Lancet. 2021 Aug 7;398(10299):535-554. (PMID: 34273294)
N Engl J Med. 2020 Feb 6;382(6):503-513. (PMID: 31995683)
J Thorac Oncol. 2019 Oct;14(10):1732-1742. (PMID: 31260833)
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907. (PMID: 20647400)
Arch Bronconeumol. 2006 Sep;42(9):446-52. (PMID: 17040660)
Clin Chest Med. 2018 Mar;39(1):45-55. (PMID: 29433724)
Ann Glob Health. 2019 Jan 22;85(1):. (PMID: 30741509)
Health Serv Res Manag Epidemiol. 2016 May 12;3:2333392816647892. (PMID: 28462278)
J Thorac Oncol. 2021 Jun;16(6):933-944. (PMID: 33607309)
PLoS One. 2018 Aug 22;13(8):e0201881. (PMID: 30133533)
Nat Rev Clin Oncol. 2021 Mar;18(3):135-151. (PMID: 33046839)
Curr Med Res Opin. 2020 Jul;36(7):1201-1207. (PMID: 32372701)
Lancet. 2018 Mar 17;391(10125):1023-1075. (PMID: 29395269)
Transl Lung Cancer Res. 2019 Aug;8(4):461-475. (PMID: 31555519)
Cancer Epidemiol. 2020 Aug;67:101737. (PMID: 32450544)
Cancer Lett. 2019 Dec 1;466:35-38. (PMID: 31541696)
Eur J Cancer Prev. 2003 Feb;12(1):57-62. (PMID: 12548111)
J Thorac Oncol. 2016 Jan;11(1):39-51. (PMID: 26762738)

Keywords: Epidemiology; Hospitalization; In-hospital mortality; Lung cancer; Spain

Date Created: 20221121 Date Completed: 20221123 Latest Revision: 20221213

20231215

PMC9680125

10.1186/s12885-022-10205-2

36411427